marijuana stocks news

Inergetics, Inc. (NRTI)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 558   430   524   480  
Cost of Revenue 438 360 310 363
Gross Profit 120   70   213   117  
Operating Expenses
Research Development 0 11 9 4
Selling General and Administrative 1,430 1,294 1,556 3,141
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss (1,310) (1,235) (1,351) (3,028)
Income from Continuing Operations
Total Other Income/Expenses Net 3,245 (3,190) 509 (1,132)
Earnings Before Interest And Taxes 1,935 (4,425) (842) (4,160)
Interest Expense 241 (8) 401 367
Income Before Tax 1,694 (4,417) (1,243) (4,527)
Income Tax Expense (376) 2
Minority Interest
Net Income From Continuing Ops 1,875 (4,418) (1,240) (4,511)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income 2,070   (4,418) (1,243) (4,527)
Preferred Stock And Other Adjustments (332) (459) (322) (258)
Net Income Applicable To Common Shares 1,738   (4,878) (1,564) (4,785)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Green Thumb Industries Inc. (GTBIF) (GTI) to Open Rise New Castle Its Ninth Retail Location in Pennsylvania

Green Thumb Industries (GTI) to Open Rise New Castle, Its Ninth Retail…

$MJNA Profiles Companies from the 3rd Annual Marijuana Business Conference

Media Blitz for Medical Marijuana, Inc. Portfolio Companies at National Marijuana Business…

 AgraFlora Organics International Inc. (AGRA) (AGFAF) Organics Reviews German Cannabis Industry

AgraFlora Organics Reviews German Cannabis Industry; Begins Immediate Cannabis Supply Integration into…

InMed Pharmaceuticals Inc. (IMLFF) Announces Transition to a Single Cannabinoid Investigational Drug Candidate – INM-755

InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate –…